Zobrazeno 1 - 10
of 12
pro vyhledávání: '"V S Bonarjee"'
Autor:
Gard M S Myrmel, Ole-Thomas Steiro, Hilde L Tjora, Jørund Langørgen, Rune Bjørneklett, Øyvind Skadberg, Vernon V S Bonarjee, Øistein R Mjelva, Eva K R Pedersen, Kjell Vikenes, Torbjørn Omland, Kristin M Aakre
Publikováno v:
Clinical Chemistry. 69:649-660
Background Acute chest pain is associated with an increased risk of death and cardiovascular events even when acute myocardial infarction (AMI) has been excluded. Growth differentiation factor-15 (GDF-15) is a strong prognostic marker in patients wit
Autor:
Hilde L. Tjora, Ole‐Thomas Steiro, Jørund Langørgen, Rune Bjørneklett, Ottar K. Nygård, Øyvind Skadberg, Vernon V. S. Bonarjee, Paul Collinson, Torbjørn Omland, Kjell Vikenes, Kristin M. Aakre
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 23 (2020)
Background Cardiac troponin (cTn) permits early rule‐out/rule‐in of patients admitted with possible non–ST‐segment–elevation myocardial infarction. In this study, we developed an admission and a 0/1 hour rule‐out/rule‐in algorithm for a
Externí odkaz:
https://doaj.org/article/3fa7799d109c448d96264c10db798567
Autor:
Renske H. Olie, Paola E. J. van der Meijden, Henri M. H. Spronk, Rene van Oerle, Stale Barvik, Vernon V. S. Bonarjee, Hugo ten Cate, Dennis W. T. Nilsen
Publikováno v:
TH Open, Vol 03, Iss 03, Pp e259-e262 (2019)
Externí odkaz:
https://doaj.org/article/d025caee3b284b27b74bbe4f56a950f6
Autor:
Vernon V. S. Bonarjee
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 5 (2018)
Multiple biomarkers may predict short and long-term prognosis in patients with coronary heart disease, but their impact is limited when used in addition to established risk factors such blood pressure, cholesterol levels, diabetes mellitus, smoking a
Externí odkaz:
https://doaj.org/article/6115e432db994457bd0f827a127161a4
Autor:
I Restan, O T Steiro, H L Tjora, J Langoergen, T Omland, P Collinson, R Bjoerneklett, K Vikenes, T Steinsvik, O Skadberg, O R Mjelva, A I Larsen, V S Bonarjee, K M Aakre
Publikováno v:
European Heart Journal. 43
Background The accuracy for early identification of non-ST-elevation myocardial infarction (NSTEMI) in the emergency department must be determined for all novel high-sensitivity cardiac troponin assays (hs-cTn). In this prospective, multi-centre stud
Autor:
G M S Myrmel, O T Steiro, H L Tjora, J Langoergen, R Bjoerneklett, Ø Skadberg, V V S Bonarjee, Ø R Mjelva, K Vikenes, T Omland, K M Aakre
Publikováno v:
European Heart Journal. 43
Background Growth differentiation factor 15 (GDF-15) is related to increased risk of death and cardiovascular events when measured at initial presentation in patients with acute chest pain. Whether follow-up measurements at 3 months provide prognosti
Autor:
O Steiro, G Myrmel, T Omland, J Langorgen, R Bjorneklett, O Skadberg, V S Bonarjee, O Mjelva, P Collinson, K M Aakre, K Vikenes
Publikováno v:
European Heart Journal. Acute Cardiovascular Care. 11
Funding Acknowledgements Type of funding sources: Private grant(s) and/or Sponsorship. Main funding source(s): Grieg Foundation and Western Norway Regional Health Authority. Background There is a growing evidence that patients with angiographic signs
Autor:
Hilde L Tjora, Ole-Thomas Steiro, Jørund Langørgen, Rune O Bjørneklett, Øyvind Skadberg, Vernon V S Bonarjee, Øistein R Mjelva, Paul Collinson, Torbjørn Omland, Kjell Vikenes, Kristin M Aakre
Publikováno v:
Clinical Chemistry
291–302
291–302
Background The European Society of Cardiology (ESC) rule-out algorithms use cutoffs optimized for exclusion of non-ST elevation myocardial infarction (NSTEMI). We investigated these and several novel algorithms for the rule-out of non-ST elevation ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e03c839906210b069f6e161c684d75f
https://hdl.handle.net/11250/2980593
https://hdl.handle.net/11250/2980593
Autor:
Dennis W. T. Nilsen, Michelle Røysland, Thor Ueland, Pål Aukrust, Annika E. Michelsen, Harry Staines, Ståle Barvik, Frederic Kontny, Jan Erik Nordrehaug, Vernon V. S. Bonarjee
Publikováno v:
Thrombosis and Haemostasis
Background Vorapaxar has been shown to reduce cardiovascular mortality in post-myocardial infarction (MI) patients. Pharmacodynamic biomarker research related to protease-activated receptor-1 (PAR-1) inhibition with vorapaxar in humans has short foll
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::558c3fb235537b59cccf2d93af957aff
https://hdl.handle.net/11250/3055273
https://hdl.handle.net/11250/3055273
Autor:
Ingar Ziad Restan, Ana Yufera Sanchez, Ole-Thomas Steiro, Pedro Lopez-Ayala, Hilde L Tjora, Jørund Langørgen, Torbjørn Omland, Jasper Boeddinghaus, Thomas Nestelberger, Luca Koechlin, Paul Collinson, Rune Bjørneklett, Kjell Vikenes, Heidi Strand, Øyvind Skadberg, Øistein R Mjelva, Alf Inge Larsen, Vernon V S Bonarjee, Christian Mueller, Kristin M Aakre
Publikováno v:
European Heart Journal: Acute Cardiovascular Care
Aims This study tested the hypothesis that combining stress-induced biomarkers (copeptin or glucose) with high-sensitivity cardiac troponin (hs-cTn) increases diagnostic accuracy for non-ST-elevation myocardial infarction (NSTEMI) in patients present